CDMO

News

US bill paints some Chinese biotechs as security threats

Legislation tabled in the US is seeking to block Chinese life sciences companies from claiming federal funding and contracts on the grounds they are a national security co

R&D

From pandemic spotlight to global progress: Navigating techn...

In an increasingly interconnected world, the transfer of technology between different stakeholders and across borders is becoming an integral process in many industries, including pharma

News

Change at the top at Recipharm as strategy shifts

Swedish contract development and manufacturing organisation (CDMO) Recipharm has appointed former Nestlé Health Sciences’ chief executive Greg Behar as its new CEO, replac

R&D

The pharma trends leading to higher demand for CDMOs

Recent discoveries and advances in pharma for lower demand illnesses/indications have resulted in an increase in the number of smaller start-up organisations.

R&D

Insulin costs & pharma manufacturing

While the pharma press often focuses on R&D and drug development, the actual manufacture of drugs is an interesting space in its own right that drives many of the trends in drug pricing

Partner Content

Radiopharma CDMO SpectronRx Continues Growth

Partner Content

SpectronRx Receives U.S. Nuclear Regulatory Commission Mater...

Leading Radiopharma CDMO Opens Second Location